15 results
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
to (a) protection of the environment, natural resources or public and worker health and safety, (b) exposure to, or the generation, management, manufacture
PREM14A
zvdvel9mr42d8w
29 Jan 21
Preliminary proxy related to merger
4:22pm
DEFA14A
EX-2.1
7m66ci
21 Dec 20
Additional proxy soliciting materials
9:17pm
8-K
EX-2.1
9mm298txtv c71d
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
S-3ASR
EX-1.2
08gro i1z7
30 Apr 20
Automatic shelf registration
4:19pm
8-K
EX-1.1
36fza4ti022ezyurwgbf
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
8-K
EX-1.1
ytq3usjokwmg8pgoqz
11 Dec 14
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12:00am
DEF 14A
4pguzp
7 Apr 14
Definitive proxy
12:00am
- Prev
- 1
- Next